


Senex Therapeutics Revenue
Biotechnology Research • Manhattan, New York, United States • 1-10 Employees
Senex Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Senex Therapeutics
Oded Biran
Founder, Board Chair
Company overview
| Headquarters | 94th street, New York, NY 10025, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
About Senex Therapeutics
Ageing and stress have been identified as potential contributors to inflammation. While stress-related inflammation often subsides on its own, there are instances where it evolves into a chronic condition. Prolonged or chronic inflammation can give rise to severe health issues, causing irreversible damage to the body. SENEX aims to disrupt the cycle of chronic inflammation through the utilization of AAV-mediated gene therapy. Initially, the company is concentrating its efforts on addressing Pulmonary Arterial Hypertension and Osteoarthritis.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Senex Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Senex Therapeutics has never raised funding before.
Senex Therapeutics Tech Stack
Discover the technologies and tools that power Senex Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Blogs
Miscellaneous
Security
Programming languages
Blogs
CDN
Issue trackers
Appointment scheduling
PaaS
JavaScript frameworks
IaaS
Frequently asked questions
4.8
40,000 users



